Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and longitudinal follow-up in Kleefstra syndrome with regression or psychotic symptoms
NL-OMON45876Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of olanzapine in Kleefstra syndrome and Schizophrenia Spectrum Disorders (SSD) (2 arms), sponsored by Radboud University Medical Center. Started Apr 2019; status: completed.
02
Drugs
olanzapine
03
Conditions
Kleefstra syndromeSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON45876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45876.